RxDoctor Payments Data

Maureen O'Brien

Pediatric Hematology-Oncology · Aurora, CONPI 1710194881

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $6,700 of the $8,868 with a category attached, or 75.5%. Pfizer accounts for 75.5% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2020 at $3,500 and has fallen 98.6% since, to $49 in 2025.

$8,868in general payments, 2019–2025

Across 6 payments — averaging $1478.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$7K
  • Jazz Pharmaceuticals Inc.$2K
  • Amgen$134
$65,988,426in research payments, 2019–2025

Across 113 payments — averaging $583,968 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$65.8M
  • AbbVie$125K
  • Amgen$74K

What the payments were for

  • Consulting fees$1,86021%
  • Speaking & faculty fees$6,70076%
  • Food & beverage$3083%

General payments by program year

19
20
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer2$6,700
Jazz Pharmaceuticals Inc.3$2,035
Amgen1$134

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,868 in reported general payments places this provider in the 70th percentile of 60 pediatric hematology-oncology providers in Colorado.

See all pediatric hematology-oncology providers in Colorado

Other pediatric hematology-oncology in Aurora

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →